Lv3
378 积分 2023-03-13 加入
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
27天前
已完结
Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy
27天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
29天前
已完结
Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism
1个月前
已完结
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6
1个月前
已完结
Molecular Mechanisms of Parathyroid Hormone Type 1 Receptor Signaling
1个月前
已完结
Synthesis and Biological Evaluations of Novel Human Parathyroid Hormone 1 Receptor (hPTHR1) Agonists Bearing Bicyclic Aromatic Moiety
1个月前
已完结
Contrasting roles for GLP-1R and GIPR in a model of diet-induced obesity
1个月前
已关闭
Generation of Acsl4 Gene Knockout Mouse Model by CRISPR/Cas9-Mediated Genome Engineering
1个月前
已完结
Targeting ACSLs to modulate ferroptosis and cancer immunity
1个月前
已完结
皖公网安备34019202002308
